Hope Mueller joined Currax Pharmaceuticals LLC in February 2022 as the SVP, Corporate Development and Strategy, bringing over 25 years of healthcare leadership experience directing corporate strategy, business development, continuous improvement, communications, operations, and quality.

Prior to joining Currax, Hope served in various VP roles at Horizon Therapeutics, including VP of Quality, VP of Continuous Improvement, VP of Quality and Integration, and VP of R&D Program and Project Management. Hope transitioned from Catalent to Crealta Pharmaceuticals (acquired by Horizon) to lead Quality, Operations, and all vendor and contract manufacturing oversight as the VP of Quality Assurance.

At Catalent, Hope scaled her level of responsibility, first as the Director of Analytical Quality, then as the Director Manufacturing and Customer Quality, and finally tackled the role of Site Head of Quality, with over 120 personnel, 38 Blow-Fill-Seal (BFS) filling lines, hundreds of products, and 30+ contract manufacturing clients. At Baxter Healthcare, in five years, she ascended from a Microbiology Analyst, through Supervisor and Manager roles, to a Senior Manager of Quality Improvement, where she drove process improvements across eight global sites.

Hope received her Bachelor of Science degree from Indiana University Bloomington in Biology, and her MBA from Northwestern University Kellogg School of Management. She is the Founder and President of Hunter Street Charity, an organization that provides support for children and families during critical times of need.